Stay updated with breaking news from Van Loock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson said it is testing a drug to prevent dengue that is the first antiviral to show activity against the virus, which infects millions of people each year and has no treatment.
A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday. There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago. “It is the first ever to show antiviral activity against dengue,” Marnix Van Loock, who oversees emerging pathogens research f...
10 volunteers were given a high dose of the pill 5 days before being injected with dengue
A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.
Dengue has long been a scourge in much of Asia and Latin America, resulting in millions of infections annually and tens of thousands of deaths